Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue

被引:18
作者
Das, S
Shraga, D
Gannon, C
Lam, TT
Feng, S
Brunet, LR
Telford, SR
Barthold, SW
Flavell, RA
Fikrig, E
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,RHEUMATOL SECT,LAB CLIN INVEST 610,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,COMPARAT MED SECT,NEW HAVEN,CT 06520
[3] YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520
[4] YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06520
[5] HARVARD UNIV,SCH PUBL HLTH,DEPT TROP PUBL HLTH,BOSTON,MA 02115
关键词
Lyme disease; Borrelia burgdorferi; p30; OppA homologue; outer surface protein;
D O I
10.1016/S0923-2508(97)85121-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A Borrelia burgdorferi chromosomal gene encodes a 30-kDa antigen (P30) that has considerable homology with periplasmic substrate-binding proteins of Gram-negative bacteria, and is recognized by antibodies in sera from a subset of patients with Lyme disease and from B. burgdorferi-infected mice. The p30 gene is 80f nucleotides in length and P30 contains 267 amino acids, with a predicted molecular mass of 30 kDa. The P30 amino acid region 36-258 has homology to conserved domains of the oligopeptide permease A of Gram-negative bacteria. Immunofluorescence studies using murine anti-P30 serum suggest that P30 is on the outer surface of B. burgdorferi. P30 expression could be detected in representatives of all 3 subspecies of B. burgdorferi sensu late, but not in all of the tested strains. Antibodies to P30 were detected in sera of 18 out of 82 patients (22%) with Lyme disease, including individuals with early- or late-stage infection. Although antibodies to P30 are present in the sera of C3H/HeN mice infected with B. burgdorferi for at least 90 days, immunization with recombinant P30 does not protect mice from infection. We conclude that P30 is a putative substrate-binding protein of B. burgdorferi and is immunologically recognized in human and murine Lyme borreliosis.
引用
收藏
页码:739 / 751
页数:13
相关论文
共 34 条
[21]   LOW-PASSAGE-ASSOCIATED PROTEINS OF BORRELIA-BURGDORFERI-B31 - CHARACTERIZATION AND MOLECULAR-CLONING OF OSPD, A SURFACE-EXPOSED, PLASMID-ENCODED LIPOPROTEIN [J].
NORRIS, SJ ;
CARTER, CJ ;
HOWELL, JK ;
BARBOUR, AG .
INFECTION AND IMMUNITY, 1992, 60 (11) :4662-4672
[22]   MOLECULAR CHARACTERIZATION AND EXPRESSION OF P23 (OSPC) FROM A NORTH-AMERICAN STRAIN OF BORRELIA-BURGDORFERI [J].
PADULA, SJ ;
SAMPIERI, A ;
DIAS, F ;
SZCZEPANSKI, A ;
RYAN, RW .
INFECTION AND IMMUNITY, 1993, 61 (12) :5097-5105
[23]   PHYLOGENETIC ANALYSIS OF THE SPIROCHETES [J].
PASTER, BJ ;
DEWHIRST, FE ;
WEISBURG, WG ;
TORDOFF, LA ;
FRASER, GJ ;
HESPELL, RB ;
STANTON, TB ;
ZABLEN, L ;
MANDELCO, L ;
WOESE, CR .
JOURNAL OF BACTERIOLOGY, 1991, 173 (19) :6101-6109
[24]   THE OLIGOPEPTIDE TRANSPORT-SYSTEM OF BACILLUS-SUBTILIS PLAYS A ROLE IN THE INITIATION OF SPORULATION [J].
PEREGO, M ;
HIGGINS, CF ;
PEARCE, SR ;
GALLAGHER, MP ;
HOCH, JA .
MOLECULAR MICROBIOLOGY, 1991, 5 (01) :173-185
[25]   PROTECTION OF C3H/HEN MICE FROM CHALLENGE WITH BORRELIA-BURGDORFERI THROUGH ACTIVE IMMUNIZATION WITH OSPA, OSPB, OR OSPC, BUT NOT WITH OSPD OR THE 83-KILODALTON ANTIGEN [J].
PROBERT, WS ;
LEFEBVRE, RB .
INFECTION AND IMMUNITY, 1994, 62 (05) :1920-1926
[26]  
Radolf Justin D., 1994, Trends in Microbiology, V2, P307, DOI 10.1016/0966-842X(94)90446-4
[27]   USE OF A HYBRID PROTEIN CONSISTING OF THE VARIABLE REGION OF THE BORRELIA-BURGDORFERI FLAGELLIN AND PART OF THE 83-KDA PROTEIN AS ANTIGEN FOR SERODIAGNOSIS OF LYME-DISEASE [J].
RASIAH, C ;
RAUER, S ;
GASSMANN, GS ;
VOGT, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) :1011-1017
[28]   CHANGES IN INFECTIVITY AND PLASMID PROFILE OF THE LYME-DISEASE SPIROCHETE, BORRELIA-BURGDORFERI, AS A RESULT OF INVITRO CULTIVATION [J].
SCHWAN, TG ;
BURGDORFER, W ;
GARON, CF .
INFECTION AND IMMUNITY, 1988, 56 (08) :1831-1836
[29]   THE 39-KILODALTON PROTEIN OF BORRELIA-BURGDORFERI - A TARGET FOR BACTERICIDAL HUMAN MONOCLONAL-ANTIBODIES [J].
SCRIBA, M ;
EBRAHIM, JS ;
SCHLOTT, T ;
EIFFERT, H .
INFECTION AND IMMUNITY, 1993, 61 (10) :4523-4526
[30]  
SEARS JE, 1991, J IMMUNOL, V147, P1995